These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 12722931)
21. Genetics of Parkinsonism: a review. Vaughan JR; Davis MB; Wood NW Ann Hum Genet; 2001 Mar; 65(Pt 2):111-26. PubMed ID: 11427172 [TBL] [Abstract][Full Text] [Related]
22. Familial and sporadic Parkinson's disease usually display the same clinical features. Carr J; de la Fuente-Fernández R; Schulzer M; Mak E; Calne SM; Calne DB Parkinsonism Relat Disord; 2003 Mar; 9(4):201-4. PubMed ID: 12618054 [TBL] [Abstract][Full Text] [Related]
23. Clinical and neuropathological features: session III summary and research needs. Forno L; Langston JW Neurotoxicology; 2001 Dec; 22(6):833-5. PubMed ID: 11829417 [No Abstract] [Full Text] [Related]
24. Molecular mechanisms of neurodegeneration in Parkinson's disease: clues from Mendelian syndromes. Lim KL; Lim TM IUBMB Life; 2003 Jun; 55(6):315-22. PubMed ID: 12938733 [TBL] [Abstract][Full Text] [Related]
25. [Gene diagnosis of Alzheimer's disease and Parkinson's disease]. Tanaka S Rinsho Byori; 2002 Oct; 50(10):965-9. PubMed ID: 12451676 [TBL] [Abstract][Full Text] [Related]
26. Recent advances in the genetics and pathogenesis of Parkinson disease. Mouradian MM Neurology; 2002 Jan; 58(2):179-85. PubMed ID: 11805242 [TBL] [Abstract][Full Text] [Related]
27. [Genetics of Parkinson's disease]. García de Yébenes J Neurologia; 2001 Jan; 16(1):1-6. PubMed ID: 11234656 [No Abstract] [Full Text] [Related]
30. Genetics of Parkinson's disease. Morris HR Ann Med; 2005; 37(2):86-96. PubMed ID: 16026116 [TBL] [Abstract][Full Text] [Related]
31. alpha-Synuclein and parkin: coming together of pieces in puzzle of Parkinson's disease. Burke RE Lancet; 2001 Nov; 358(9293):1567-8. PubMed ID: 11716878 [No Abstract] [Full Text] [Related]
32. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease. McNaught KS; Olanow CW Ann Neurol; 2003; 53 Suppl 3():S73-84; discussion S84-6. PubMed ID: 12666100 [TBL] [Abstract][Full Text] [Related]
33. [Genetics and environmental factors of Parkinson disease]. Broussolle E; Thobois S Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S11-23. PubMed ID: 12690660 [TBL] [Abstract][Full Text] [Related]
34. Genetics of Parkinson's disease. Mizuno Y; Hattori N; Mori H Biomed Pharmacother; 1999 Apr; 53(3):109-16. PubMed ID: 10349506 [TBL] [Abstract][Full Text] [Related]
35. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease]. Corti O; Brice A J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640 [TBL] [Abstract][Full Text] [Related]
36. [Progress in diagnosis and therapy for Parkinson's disease]. Mizuno Y Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2344-8. PubMed ID: 12373846 [No Abstract] [Full Text] [Related]
37. The cast of molecular characters in Parkinson's disease: felons, conspirators, and suspects. Lim KL; Dawson VL; Dawson TM Ann N Y Acad Sci; 2003 Jun; 991():80-92. PubMed ID: 12846976 [TBL] [Abstract][Full Text] [Related]
38. Linkage exclusion in French families with probable Parkinson' s disease. Farrer M; Destée T; Becquet E; Wavrant-De Vrièze F; Mouroux V; Richard F; Defebvre L; Lincoln S; Hardy J; Amouyel P; Chartier-Harlin MC Mov Disord; 2000 Nov; 15(6):1075-83. PubMed ID: 11104189 [TBL] [Abstract][Full Text] [Related]
39. Parkinson's genetics: molecular insights for the new millennium. Skipper L; Farrer M Neurotoxicology; 2002 Oct; 23(4-5):503-14. PubMed ID: 12428722 [TBL] [Abstract][Full Text] [Related]
40. New movement in Parkinson's. Lozano AM; Kalia SK Sci Am; 2005 Jul; 293(1):68-75. PubMed ID: 16008304 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]